HILLS & DALES GENERAL HOSPITAL — History
CCN 231316 | 3-year financial timeline | COVID resilience: 70/100
🛡️ Public data only — no PHI permitted on this instance.
$41M
Latest Revenue (FY2022)
+8.9%
Revenue CAGR (3yr)
1.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $35M | $37M | $41M | +11.1% | +8.9% |
| Operating Expenses | $36M | $37M | $41M | +9.2% | +6.2% |
| Operating Margin | -3.8% | -0.5% | 1.2% | +361.0% | +0.0% |
| Net Income | $-1M | $-0M | $0M | +389.9% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 1,451 | 1,394 | 2,160 | +54.9% | +22.0% |
| Medicare Day % | 64% | 61% | 51% | -16.3% | -10.6% |
| Medicaid Day % | 1% | 1% | 1% | +19.9% | -1.5% |
COVID Impact & Recovery
Resilience Score: 70/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +18.5% ($35M → $41M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.9%
This Hospital
+7.6%
State Avg
Latest Margin
1.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $44M | 3.7% |
| FY2024 (proj) | $48M | 6.2% |
| FY2025 (proj) | $51M | 8.7% |